254 related articles for article (PubMed ID: 31078921)
1. Natural killer cells involved in tumour immune escape of hepatocellular carcinomar.
Han C; Jiang Y; Wang Z; Wang H
Int Immunopharmacol; 2019 Aug; 73():10-16. PubMed ID: 31078921
[TBL] [Abstract][Full Text] [Related]
2. Down-regulation of PR/SET domain 10 underlies natural killer cell dysfunction in hepatocellular carcinoma.
Han J; Ke C; Jiang B; Zhou H; Xu H; Xie X
Clin Exp Immunol; 2021 Dec; 206(3):366-377. PubMed ID: 34562314
[TBL] [Abstract][Full Text] [Related]
3. NK cell receptor imbalance and NK cell dysfunction in HBV infection and hepatocellular carcinoma.
Sun C; Sun H; Zhang C; Tian Z
Cell Mol Immunol; 2015 May; 12(3):292-302. PubMed ID: 25308752
[TBL] [Abstract][Full Text] [Related]
4. Natural Killer Cells in Liver Disease and Hepatocellular Carcinoma and the NK Cell-Based Immunotherapy.
Liu P; Chen L; Zhang H
J Immunol Res; 2018; 2018():1206737. PubMed ID: 30255103
[TBL] [Abstract][Full Text] [Related]
5. RNA interfering targeting human leukocyte antigen-G enhanced immune surveillance mediated by the natural killer cells on hepatocellular carcinoma.
Zeng XC; Zhang T; Huang DH; Wang GY; Chen W; Li H; Zhang J; Fang TL; Zhang Q; Chen GH
Ann Clin Lab Sci; 2013; 43(2):135-44. PubMed ID: 23694787
[TBL] [Abstract][Full Text] [Related]
6. Natural Killer Cells and Regulatory T Cells Cross Talk in Hepatocellular Carcinoma: Exploring Therapeutic Options for the Next Decade.
Bozward AG; Warricker F; Oo YH; Khakoo SI
Front Immunol; 2021; 12():643310. PubMed ID: 33995362
[TBL] [Abstract][Full Text] [Related]
7. Tim-3 Hampers Tumor Surveillance of Liver-Resident and Conventional NK Cells by Disrupting PI3K Signaling.
Tan S; Xu Y; Wang Z; Wang T; Du X; Song X; Guo X; Peng J; Zhang J; Liang Y; Lu J; Peng J; Gao C; Wu Z; Li C; Li N; Gao L; Liang X; Ma C
Cancer Res; 2020 Mar; 80(5):1130-1142. PubMed ID: 31848194
[TBL] [Abstract][Full Text] [Related]
8. Natural killer and activated killer activities in chronic liver disease and hepatocellular carcinoma: evidence for a decreased lymphokine-induced activity of effector cells.
Hirofuji H; Kakumu S; Fuji A; Ohtani Y; Murase K; Tahara H
Clin Exp Immunol; 1987 May; 68(2):348-56. PubMed ID: 2820634
[TBL] [Abstract][Full Text] [Related]
9. Natural Killer Cell Dysfunction in Hepatocellular Carcinoma: Pathogenesis and Clinical Implications.
Sung PS; Jang JW
Int J Mol Sci; 2018 Nov; 19(11):. PubMed ID: 30463262
[TBL] [Abstract][Full Text] [Related]
10. Monocyte/macrophage-elicited natural killer cell dysfunction in hepatocellular carcinoma is mediated by CD48/2B4 interactions.
Wu Y; Kuang DM; Pan WD; Wan YL; Lao XM; Wang D; Li XF; Zheng L
Hepatology; 2013 Mar; 57(3):1107-16. PubMed ID: 23225218
[TBL] [Abstract][Full Text] [Related]
11. Mechanism of tumor cells escaping from immune surveillance of NK cells.
Ge Z; Wu S; Zhang Z; Ding S
Immunopharmacol Immunotoxicol; 2020 Jun; 42(3):187-198. PubMed ID: 32223464
[TBL] [Abstract][Full Text] [Related]
12. MiR-506 Promotes Natural Killer Cell Cytotoxicity against Human Hepatocellular Carcinoma Cells by Targeting STAT3.
Su Z; Ye X; Shang L
Yonsei Med J; 2019 Jan; 60(1):22-29. PubMed ID: 30554487
[TBL] [Abstract][Full Text] [Related]
13. Granulin-epithelin precursor renders hepatocellular carcinoma cells resistant to natural killer cytotoxicity.
Cheung PF; Yip CW; Wong NC; Fong DY; Ng LW; Wan AM; Wong CK; Cheung TT; Ng IO; Poon RT; Fan ST; Cheung ST
Cancer Immunol Res; 2014 Dec; 2(12):1209-19. PubMed ID: 25315249
[TBL] [Abstract][Full Text] [Related]
14. Taste receptor T1R1/T1R3 promotes the tumoricidal activity of hepatic CD49a
Liu S; Xu M; Zhu C; Zhao Q; Zhou F
Eur J Immunol; 2018 Dec; 48(12):2031-2041. PubMed ID: 30259960
[TBL] [Abstract][Full Text] [Related]
15. Frequency and Implications of Natural Killer and Natural Killer T Cells in Hepatocellular Carcinoma.
Zahran AM; Abdel-Meguid MM; Ashmawy AM; Rayan A; Elkady A; Elsherbiny NM; Hetta HF
Egypt J Immunol; 2018 Jun; 25(2):45-52. PubMed ID: 30600947
[TBL] [Abstract][Full Text] [Related]
16. Trichostatin A Sensitizes Hepatocellular Carcinoma Cells to Enhanced NK Cell-mediated Killing by Regulating Immune-related Genes.
Shin S; Kim M; Lee SJ; Park KS; Lee CH
Cancer Genomics Proteomics; 2017; 14(5):349-362. PubMed ID: 28871002
[TBL] [Abstract][Full Text] [Related]
17. IL-21 reinvigorates exhausted natural killer cells in patients with HBV-associated hepatocellular carcinoma in STAT1-depedent pathway.
Jin Y; Sun Z; Geng J; Yang L; Song Z; Song H; Wang J; Tang J
Int Immunopharmacol; 2019 May; 70():1-8. PubMed ID: 30780004
[TBL] [Abstract][Full Text] [Related]
18. Natural killer cell dysfunction in hepatocellular carcinoma and NK cell-based immunotherapy.
Sun C; Sun HY; Xiao WH; Zhang C; Tian ZG
Acta Pharmacol Sin; 2015 Oct; 36(10):1191-9. PubMed ID: 26073325
[TBL] [Abstract][Full Text] [Related]
19. Natural Killer Cells and T Cells in Hepatocellular Carcinoma and Viral Hepatitis: Current Status and Perspectives for Future Immunotherapeutic Approaches.
Kalathil SG; Thanavala Y
Cells; 2021 May; 10(6):. PubMed ID: 34071188
[TBL] [Abstract][Full Text] [Related]
20. UPR decreases CD226 ligand CD155 expression and sensitivity to NK cell-mediated cytotoxicity in hepatoma cells.
Gong J; Fang L; Liu R; Wang Y; Xing J; Chen Y; Zhuang R; Zhang Y; Zhang C; Yang A; Zhang X; Jin B; Chen L
Eur J Immunol; 2014 Dec; 44(12):3758-67. PubMed ID: 25209846
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
